Pagina inicial
Continue Watching
Últimos vídeos
Últimos vídeos
Brightcove Home Latest Listing
Oncology
Oncology
Brightcove Cards Listing
Hematology
Hematology
Brightcove Cards Listing
Popular em MedEnrich
Popular em MedEnrich
Popular in Sem nome
Câncer de próstata11m 38s
Treatment Intensification in Metastatic Castration Sensitive Prostate Cancer
PEACE-1 clinical trial demonstrated that combining ADT and docetaxel with abiraterone acetate plus prednisone (AAP) improves both overall survival (OS) and radiographic progression-free-survival (rPFS) in men with de novo mCSPC.
treatment intensification
mhspc
triplet therapy
peace-1 clinical trial
1
Treatment Intensification in Metastatic Castration...
Oncospecials15m 30s
A Relevância dos Agentes TKI na era das imunoterapias para o tratamento do carcinoma de células Renais
ONCOPLUS apresenta: vídeo-aula com Dr. Denis Jardim na patologia de carcinoma de células renais.
oncologia
ccr
câncer renal
tki
sunitinibe
1
A Relevância dos Agentes TKI na era das...
Myelodysplastic Syndromes14m 13s
ASH 2022 Update on Myelodysplastic Syndromes
ASH 2022 - Update on Myelodysplastic Syndromes
low risk mds
venetoclax
viale -a
eln classification
low dose lenalidomide
tags: azacitidine
1
ASH 2022 Update on Myelodysplastic Syndromes
Mieloma múltiplo9m 20s
Integrating Pomalidomide Based Regimens in Multiple Myeloma
Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
pomalidomide-dexamethasone
rrmm management
progression-free survival
combination therapies
1
Integrating Pomalidomide Based Regimens in Multiple...
Mieloma múltiplo17m 14s
Tratamento do mieloma múltiplo
Tratamento do mieloma multiplo_Dr Ederson Mattos
mm
mieloma múltiplo
tratamento
lenalidomida
nccn
ederson mattos
1
Tratamento do mieloma múltiplo
Acute Myeloid Leukaemia12m 22s
EHA 2022 Updates : AML
EHA Updates AML : QuANTUM phase 3 study showed significant overall survival in adults having FLT3-ITD+ acute myeloid leukaemia with addition of quizartinib to standard induction and consolidation therapy alone.
aml
decitabine
g-csf
hypomethylating agents
1
EHA 2022 Updates : AML
3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
her2 positive mbc
prolonged remission
trastuzumab duration
1
Duration of trastuzumab in patients with Her2...
3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
her2 positive mbc
prolonged remission
trastuzumab duration
1
Duration of trastuzumab in patients with Her2...
Oncospecials14m 58s
Is TKI Monotherapy still relevant for advanced Renal Cell carcinoma
ICIs in combination with VEGF-targeted treatments have become standard of care in 1st line advanced RCC ,however there are certain group of patients wherein treatment with single agent TKI can still be considered optimal
1st line rcc
single agent tki
1
Is TKI Monotherapy still relevant for advanced...
Oncospecials4m 33s
Case of Advanced Renal Cell Carcinoma patient with Rheumatoid Arthritis treated with single agent TKI
Learn about successful treatment of 72 year old Renal Cell Carcinoma Patient also suffering from Rheumatoid Arthritis treated with single agent TKI
renal cell carcinoma
rheumatoid arthritis
single agent tki
1